Josephine Lloyd

Papers

Total Citations

H-Index

About

Josephine Lloyd is a urologic oncologist whose research focuses on refining risk stratification and surgical outcomes for prostate cancer, particularly in high-risk disease. Her most cited work, "Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?" (2021, 7 citations), challenges conventional staging by investigating whether tumor volume—often overlooked in favor of PSA, ISUP grade group, and multiparametric MRI—can independently predict patient outcomes. This contribution underscores her commitment to integrating quantitative pathology into clinical decision-making, potentially improving prognostic accuracy for men undergoing radical prostatectomy. Beyond this study, Lloyd’s broader research portfolio examines the interplay between surgical technique, tumor biology, and long-term survival, aiming to personalize treatment for aggressive prostate cancers. Her work has been cited in leading urology journals, reflecting its relevance to ongoing debates about staging criteria. Lloyd’s findings advocate for a more nuanced approach to high-risk disease, where tumor volume may serve as a critical, yet underutilized, metric. For students and researchers, her research highlights the importance of questioning established norms and leveraging detailed pathological data to enhance predictive models in oncology.